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June 16, 2009:2309–13etitive athletes. All efforts should be made to identify and manage
ounger affected family members before life-threatening ventricu-
ar arrhythmias occur. These efforts are justified by the recognition
hat early diagnosis and timely therapy, predominantly by implant-
ble defibrillator, provides life-saving protection (3). Although we
gree with the comments that a nationwide clinical and genetic
creening for inherited heart diseases is warranted, we believe that
re-participation evaluation of young competitive athletes and
amilial cascade screening should not be considered mutually
xclusive—rather, they should interact synergistically to achieve
arly (pre-symptomatic) identification of individuals affected by
nherited cardiomyopathies at risk of sudden cardiac death.
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re-Participation
ports Clearance
s an outspoken critic of the current state of pre-sports screening
n the U.S. (1), I applaud Corrado et al. (2) and Pelliccia et al. (3)
or their scientific and thorough efforts to detect conditions
esponsible for sudden cardiac death in athletes and adopting
tandardized procedures for screening. Although I agree that
outine electrocardiograms (ECGs) can help detect hypertrophic
ardiomyopathy, long-QT syndrome, and arrhythmogenic right
entricular dysplasia, there is one diagnosis for which ECGs seem
nhelpful: congenital anomalies of the origin of the coronary
rteries (4,5).
Basso et al. (5) himself reported that this diagnosis is
esponsible for between 5% and 35% of all sudden cardiac death
n adolescents. As a result, I was surprised that this diagnosis
as given little attention by these articles. Corrado et al. (2)
umped congenital anomalies of the origin of the coronary
rteries with premature coronary artery disease. These 2 diag-
oses have different demographics, etiologies, prevalences, pre- dentations, and suitability of screening. As far as I know, the
ndings listed in the chart on page 1,984 of his article are all
iagnostic for premature coronary artery disease and are of
imited or no value in diagnosing congenital anomalies of the
rigin of the coronary arteries (2,4). Pelliccia et al. (3) failed to
ention both diagnoses in their article.
In my pediatric cardiology practice, congenital anomalies of the
rigin of the coronary arteries is the diagnostic possibility of the
ost concern in athletes, especially ones complaining of nonspe-
ific symptoms such as chest pain. I order more echocardiograms
n young athletes and spend more time personally performing and
eviewing echocardiograms to make this diagnosis than with
ypertrophic obstructive cardiomyopathy or long-QT syndrome,
hich are easier to diagnose with echocardiogram and ECG. It
eems to me that no matter how powerful the ECG is for screening
or the other diagnoses, we are still going to have to evaluate and
ersonally do an echocardiogram on nearly all competitive athletes
f we are going to rule out congenital anomalies of the origin of the
oronary arteries and thus significantly reduce the incidence of
udden cardiac death in adolescent athletes. I fail to see how this
s financially feasible.
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eply
e thank Dr. Reich for his interest in our review (1). We agree
ith his comments that congenital coronary artery anomaly is
n important cause of sudden death in young competitive
thletes and that its clinical detection in young competitive
thletes undergoing pre-participation screening is challenging.
he most frequent anatomical variant leading to cardiac arrest
onsists of both coronary arteries arising either from the right or
he left coronary sinus, with the aberrant coronary artery
oursing between the aorta and the pulmonary trunk. Retro-
pective analyses of clinical and pathological series have consis-
ently shown that neither routine 12-lead electrocardiogram
ECG) nor exercise testing are particularly informative for the
iagnosis of the anomalous origin of a coronary artery from the
